Table 5.

Prevalence (positive predictive value) of cytologic abnormalities among women testing positive for HR HPV types by age group and HPV test, Vanuatu 2009–2010

Cytologya
NormalLSILHSIL+; cancers
HPV testAge, yHR HPV+n (%)n (%)n (%)
PCR15–2911269 (61.6)33 (29.5)10 (8.9)
30–395736 (63.2)7 (12.3)14; 4 (24.6)
40+1910 (52.6)2 (10.5)7; 3 (36.8)
Total188115 (61.2)42 (22.3)31; 7 (15.5)
HC215–298243 (52.4)30 (36.6)9 (11.0)
30–393416 (47.1)5 (14.7)13; 3 (38.2)
40+2012 (60.0)2 (10.0)6; 2 (30.0)
Total13671 (52.2)37 (27.2)28; 5 (20.6)

aTwenty-six and 12 women who were positive for HR HPV types by PCR assay and HC2, respectively, had to be excluded because of inadequate cytology.